Andreas Savopoulos
Hematology & Oncology · West Orange, NJNPI 1972660496
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,077 of the $4,757 with a category attached, or 85.7%. It is spread thinly across 36 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,253 and has fallen 90.7% since, to $117 in 2024.
Across 247 payments — averaging $19.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$637
- Novartis$567
- Johnson & Johnson$420
- Incyte Corporation$420
- E.r. Squibb & Sons, L.L.C.$380
- Lilly USA, LLC$274
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,07786%
- Education$68014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 28 | $637 |
| Novartis | 33 | $567 |
| Johnson & Johnson | 13 | $420 |
| Incyte Corporation | 18 | $420 |
| E.r. Squibb & Sons, L.L.C. | 20 | $380 |
| Lilly USA, LLC | 11 | $274 |
| Boehringer Ingelheim | 17 | $197 |
| Sanofi | 5 | $194 |
| Bayer | 10 | $174 |
| Pfizer | 10 | $139 |
| Merck | 9 | $137 |
| Gilead | 3 | $133 |
| Amgen | 8 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $121 |
| Eisai Inc. | 8 | $118 |
| Bristol Myers Squibb | 8 | $104 |
| Daiichi Sankyo Inc. | 4 | $89 |
| Rigel Pharmaceuticals, Inc. | 4 | $66 |
| GSK | 4 | $54 |
| Puma Biotechnology, Inc. | 4 | $49 |
| Morphosys, US Inc. | 2 | $33 |
| Apellis Pharmaceuticals, Inc. | 2 | $32 |
| Mirati Therapeutics, Inc. | 2 | $31 |
| CTI Biopharma Corp. | 2 | $30 |
| Dova Pharmaceuticals | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 2 | $28 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $27 |
| Emmaus Medical, Inc. | 1 | $25 |
| Secura Bio, Inc. | 1 | $21 |
| Taiho Oncology, Inc. | 1 | $19 |
| Macrogenics, Inc. | 1 | $18 |
| Octapharma USA, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $12 |
| Tesaro, Inc. | 1 | $12 |
| EMD Serono, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,757 in reported general payments places this provider in the 60th percentile of 362 hematology & oncology providers in New Jersey.
Other hematology & oncology in West Orange
- Robert SpiegelWestfield$864K
- Amit PatelJersey City$770K
- Joshua StraussSpringfield$739K
- Charles FarberMorristown$609K
- Michael ScolaMorristown$506K
- Eshan PatelSomerville$420K
- Arturo Loaiza-BonillaPennington$406K
- Ashish ShahSpringfield$394K
- Carl HenningsonManasquan$349K
- Anthony BottiLivingston$275K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.